Hidetake Tachinami
Toyama, 9300194, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Innate Immune Modulation via TLR3 Activation Suppresses Orthotopic Oral Squamous Cell Carcinoma Growth.
Journal: Biological & pharmaceutical bulletin
Published: August 12, 2026
Targeting CD36-Mediated Lipid Metabolism by Selective Inhibitor-Augmented Antitumor Immune Responses in Oral Cancer.
Journal: International journal of molecular sciences
Published: July 05, 2024
PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma.
Journal: Scientific reports
Published: November 02, 2023
Treatment of severe micrognathia in an adult with distraction osteogenesis: A case report.
Journal: Clinical case reports
Published: March 08, 2023
Successful treatment with nivolumab in a patient with unresectable oral squamous cell carcinoma following ineffective chemoradiotherapy.
Journal: Clinical case reports
Published: February 08, 2023
Neutrophil-to-Lymphocyte Ratio(NLR)as a Predictive Indicator of the Response to Nivolumab in Patients with Oral Squamous Cell Carcinoma
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 16, 2021
Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab.
Journal: The British journal of oral & maxillofacial surgery
Published: September 13, 2021
Novel strategy to predict high risk of inferior alveolar nerve injury during extraction of lower third molars based on assessment of computed tomographic images of multiple anatomical features.
Journal: The British journal of oral & maxillofacial surgery
Published: June 22, 2021
Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report.
Journal: Clinical case reports
Published: April 05, 2021
Last Updated: 09/26/2026